RT Journal Article
SR Electronic
T1 Simulating a community mental health service during the COVID-19 pandemic: effects of clinician–clinician encounters, clinician–patient–family encounters, symptom-triggered protective behaviour, and household clustering
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.27.20081505
DO 10.1101/2020.04.27.20081505
A1 Rudolf N. Cardinal
A1 Caroline E. Meiser-Stedman
A1 David M. Christmas
A1 Annabel C. Price
A1 Chess Denman
A1 Benjamin R. Underwood
A1 Shanquan Chen
A1 Soumya Banerjee
A1 Simon R. White
A1 Li Su
A1 Tamsin J. Ford
A1 Samuel R. Chamberlain
A1 Catherine M. Walsh
YR 2020
UL http://medrxiv.org/content/early/2020/05/03/2020.04.27.20081505.abstract
AB Background Face-to-face healthcare, including psychiatric provision, must continue despite reduced interpersonal contact during the COVID-19 (SARS-CoV-2 coronavirus) pandemic. Community-based services might use domiciliary visits, consultations in healthcare settings, or remote consultations. Services might also alter direct contact between clinicians.Aims We examined the effects of appointment types and clinician–clinician encounters upon infection rates.Methods We modelled a COVID-19-like disease in a hypothetical community healthcare team, their patients, and patients’ household contacts (family). In one condition, clinicians met patients and briefly met family (e.g. home visit or collateral history). In another, patients attended alone (e.g. clinic visit), segregated from each other. In another, face-to-face contact was eliminated (e.g. videoconferencing). We also varied clinician–clinician contact; baseline and ongoing “external” infection rates; whether overt symptoms reduced transmission risk behaviourally (e.g. via personal protective equipment, PPE); and household clustering.Results Service organization had minimal effects on whole-population infection under our assumptions but materially affected clinician infection. Appointment type and inter-clinician contact had greater effects at low external infection rates and without a behavioural symptom response. Clustering magnified the effect of appointment type. We discuss infection control and other factors affecting appointment choice and team organization.Conclusions Distancing between clinicians can have significant effects on team infection. Loss of clinicians to infection likely has an adverse impact on care, not modelled here. Appointments must account for clinical necessity as well as infection control. Interventions to reduce transmission risk can synergize, arguing for maximal distancing and behavioural measures (e.g. PPE) consistent with safe care.Competing Interest StatementRNC consults for Campden Instruments Ltd and receives royalties from Cambridge University Press, Cambridge Enterprise, and Routledge. BRU is clinical director of the Windsor Unit at Fulbourn Hospital, which delivers clinical trials in dementia/mild cognitive impairment for academic and commercial organisations without personal benefit, and is the clinical lead for dementia for the UK National Institute for Health Research (NIHR) Clinical Research Network in the East of England. SRC consults for Promentis and Ieso Digital Health.Funding StatementRNC’s, SC’s, and SB’s research is supported by the UK Medical Research Council (grant MC_PC_17213 to RNC). SRC is funded by a Wellcome Trust Clinical Fellowship (110049/Z/15/Z). This research was supported in part by the NIHR Cambridge Biomedical Research Centre; the views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSource code is available at https://github.com/RudolfCardinal/covid. https://github.com/RudolfCardinal/covid